
这个市场不适合进入,结论很直接:新品牌没有任何可复制的成功样本,整体已经是高压竞争、低容错环境。 现在看不是“谁更会做就能赢”的市场,而是新上架基本全亏、价格和投放压力都很重的市场;你有50万人民币,够做单个ASIN的前期启动,但不够改变这个市场的胜负结构。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不值得进入,用户预算够做单个ASIN的早期启动,但不够支撑真正竞争。 这不是一个适合新卖家或小品牌切入的市场:新品牌新上架盈利率是0%,新上架非盈利率是100%,整体可判定盈利的产品里只有16.67%赚钱,市场已经明显偏向低回报和高对抗。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入:新品牌新上架成功率为0%,整体可盈利产品仅16.67%,而所有新上架样本全部不赚钱,说明这里不是机会市场,而是被头部品牌和价格压力压住的市场。 你有50万人民币预算,理论上能覆盖单个ASIN前期投入,但从样本看,钱不是主要问题,真正的问题是新品很难跑出正收益,尤其新品牌几乎没有可复制的成功样本。
这个市场不值得进入,结论是直接放弃。 目前样本里新产品成功率是0%,而所有可见的新发布产品都是非盈利;同时已出现新品牌MOMMED和老品牌PHILIPS都在新发布上失败,说明这里不是“谁更聪明谁赢”,而是市场已经进入高压竞争、低容错阶段。
从数据看,只有6个可识别利润样本里,盈利产品仅1个,利润率20.76%(PHILIPS 的 B0BWFRQSFH,月销30、月营收£1194.6、月利润£248);但新产品这边更差,3个已知新发布产品里0个盈利、3个全亏,最新的 MOMMED B0FQBTSJSM 虽然表面有27.14%利润率、月销50、月营收£4884、月利润£1325.52,但平台仍判定它非盈利,且早期投入高达$11,364.09,其中广告就占$2,555.78,这更像是靠重投放硬撑出来的样板,不是小商家可复制的稳定模型。MOMMED 作为新品牌,2个新发布全失败;PHILIPS 作为老品牌,1个新发布也失败,说明新老品牌都没有跑通,小商家想不靠激进投放/强品牌/额外研发直接切入,基本没有机会。
趋势也在恶化:2025年只有1个新发布且失败,2026年已经出现2个新发布失败,说明新发布在加速但成功没跟上,竞争是在往更差的方向走。对你来说,500000 CNY 预算虽然看起来够做单个ASIN,但这只是入场钱,不含研发、品牌、认证;而当前市场里没有任何“干净的小商家成功案例”,也没有可证明低投入能赢的路径。结论:不要进;大品牌也不值得进,小商家更不可能稳妥成功。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0BWFRQSFH | PHILIPS | 2023-02-21 | Yes | £39.82 | 30pcs | £1194.6 | 20.76% | £248.0 |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0FQBTSJSM | MOMMED | 2025-07-30 | No | £97.68 | 50pcs | £4884.0 | 27.14% | £1325.52 |
![]() | B0GZTNCDQ4 | MOMMED | 2026-04-20 | No | £- | -pcs | £- | -% | £- |
![]() | B0GVNJDPWC | PHILIPS | 2026-04-01 | No | £- | -pcs | £- | -% | £- |
这不是一个适合进入的市场:新品牌新上架成功率为0%,整体可识别盈利率仅16.67%,而新产品盈利率为0%,说明这里已经被成熟品牌和同质化产品压得很死,典型的价格战/高门槛市场,不建议继续。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入,已经接近/进入失血状态:新品牌只有1个,近两次新品牌上新全部失败,最近的新进入成功率是0%,而且 2025-2026 的新增几乎都落在非盈利区,说明竞争在加剧、利润在被压扁。 现有数据里没有看到“真正可复制的小品牌成功案例”,反而更像是大牌和重营销在硬撑,用户 50万人民币预算也只能覆盖单个 ASIN 的前期投入,无法对抗这种环境。
证据很直接: 市场里可识别的品牌只有 3 个,其中新品牌只有 MOMMED 1 个,且它的 2 个新产品全部非盈利,品牌成功率 0%;最新新产品 B0FQBTSJSM(MOMMED)售价约 £97.68,月销 50 件,月营收 £4884,但仍被判定为非盈利,早期投入约 $11364.09,其中广告就占 $2555.78,说明“看起来卖得动”不等于能赚钱。更关键的是,市场整体盈利产品占比只有 16.67%,而新发布产品盈利率是 0.00%;时间上看,2022-2024 几乎没有新释放记录,2025 和 2026 才开始出现少量新进入,但全部是非盈利,属于低成功率+利润被压缩的典型信号,不是可以放心进场的机会。
结论很明确: 大品牌这边没有看到健康扩张窗口,现有案例更多依赖品牌力和投放,单靠 50万人民币做单品也不安全;小 бизнес 更不应进,因为没有任何低门槛、低评论的真实成功样本,反而要防范像 MOMMED 这类“高预算、低回报”的失败新进入。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |